FDA Requests Removal of All Ranitidine Products (Zantac) from …
WEBThe FDA announced in April 2020 that it is requesting manufacturers to withdraw all ranitidine drugs due to the risk of NDMA contamination. NDMA is a probable human …
See results only from fda.govStatement alerting patients a…
The U.S. Food and Drug Administration has learned that some ranitidine medicines, …
Statement on new testing res…
Over the past several weeks, the FDA has been investigating the detection of a …
Delaware top court will hear drugmakers' appeal to end Zantac …
WEBAug 27, 2024 · The litigation began after the U.S. Food and Drug Administration in 2020 asked manufacturers to pull the drug off the market over concerns that ranitidine, the …
Sanofi to settle 4,000 Zantac cancer lawsuits in US state …
WEBApr 5, 2024 · Some tests showed that Zantac’s active ingredient, ranitidine, could degrade into NDMA over time or when exposed to …
- Estimated Reading Time: 3 mins
The FDA Announces Two More Antacid Recalls Due to …
WEBJan 10, 2020 · On Wednesday, the Food and Drug Administration announced voluntary recalls of prescription forms of ranitidine by two generic drug companies, Appco Pharma and Northwind …
GSK shares tumble after Delaware court ruling on Zantac
WEBJun 3, 2024 · GSK shares dropped almost 10 per cent on Monday after a ruling from a Delaware judge left the UK drugmaker exposed to US jury trials over its allegedly …
Drugmakers' appeal to end Zantac cancer lawsuits …
WEBJul 1, 2024 · Lawsuits began piling up after the U.S. Food and Drug Administration in 2020 asked manufacturers to pull the drug off the market over concerns that ranitidine could degrade into a cancer-causing...
Statement alerting patients and health care professionals of …
WEBThe FDA has found low levels of NDMA, a probable human carcinogen, in some ranitidine products, including Zantac. The agency is investigating the source and risk of this …
GSK set to face jury trials over heartburn drug Zantac
WEBJun 1, 2024 · The US Food and Drug Administration and the European Medicines Agency recommended suspension of the use of ranitidine products and the FDA asked all manufacturers to withdraw products …
Statement on new testing results, including low levels of impurities …
WEBOver the past several weeks, the FDA has been investigating the detection of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications, commonly …
Zantac Lawsuit: Status, Eligibility, & Settlements
WEBSep 3, 2024 · FDA found Zantac’s active ingredient ranitidine contained N-Nitrosodimethylamine (‘NDMA’) — a probable human carcinogen. One plaintiff, using the initials VB to protect her privacy, told Drugwatch that …
Skip to content
